 Denis Bensard
Concepts (555)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds, Nonpenetrating | 35 | 2022 | 320 | 7.130 |
Why?
| | Wounds and Injuries | 23 | 2025 | 960 | 4.280 |
Why?
| | Trauma Centers | 40 | 2023 | 469 | 4.160 |
Why?
| | Shock | 9 | 2025 | 109 | 3.680 |
Why?
| | Injury Severity Score | 45 | 2023 | 602 | 3.460 |
Why?
| | Abdominal Injuries | 13 | 2022 | 127 | 2.870 |
Why?
| | Blood Transfusion | 17 | 2022 | 405 | 2.620 |
Why?
| | Shock, Hemorrhagic | 6 | 2021 | 202 | 2.150 |
Why?
| | Glasgow Coma Scale | 8 | 2023 | 214 | 2.020 |
Why?
| | Wounds, Penetrating | 5 | 2023 | 73 | 1.810 |
Why?
| | Triage | 9 | 2025 | 247 | 1.670 |
Why?
| | Spleen | 7 | 2021 | 518 | 1.560 |
Why?
| | Craniocerebral Trauma | 6 | 2022 | 177 | 1.520 |
Why?
| | Child | 101 | 2025 | 22620 | 1.490 |
Why?
| | Brain Injuries | 9 | 2015 | 507 | 1.460 |
Why?
| | Blood Coagulation Disorders | 5 | 2022 | 190 | 1.400 |
Why?
| | Retrospective Studies | 73 | 2025 | 16937 | 1.390 |
Why?
| | Thoracic Injuries | 4 | 2018 | 73 | 1.350 |
Why?
| | Thoracotomy | 8 | 2020 | 83 | 1.340 |
Why?
| | Blood Component Transfusion | 3 | 2022 | 103 | 1.220 |
Why?
| | Child, Preschool | 62 | 2025 | 11740 | 1.140 |
Why?
| | Thrombelastography | 5 | 2022 | 178 | 1.100 |
Why?
| | Liver | 9 | 2021 | 1853 | 1.080 |
Why?
| | Tomography, X-Ray Computed | 15 | 2022 | 2798 | 1.050 |
Why?
| | Laparoscopy | 11 | 2015 | 477 | 1.040 |
Why?
| | Adolescent | 66 | 2025 | 22396 | 0.950 |
Why?
| | Appendicitis | 7 | 2021 | 148 | 0.940 |
Why?
| | Appendectomy | 6 | 2021 | 89 | 0.910 |
Why?
| | Resuscitation | 5 | 2022 | 303 | 0.910 |
Why?
| | Emergency Service, Hospital | 8 | 2023 | 2281 | 0.880 |
Why?
| | Hematocrit | 2 | 2015 | 107 | 0.860 |
Why?
| | Infant | 48 | 2025 | 9987 | 0.840 |
Why?
| | Erythrocyte Transfusion | 3 | 2022 | 228 | 0.770 |
Why?
| | Decision Support Techniques | 4 | 2022 | 447 | 0.760 |
Why?
| | Emergency Medical Services | 3 | 2023 | 690 | 0.740 |
Why?
| | Child Abuse | 6 | 2014 | 550 | 0.740 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2940 | 0.740 |
Why?
| | Humans | 137 | 2025 | 144857 | 0.740 |
Why?
| | Heart Rate | 6 | 2023 | 847 | 0.740 |
Why?
| | Length of Stay | 13 | 2022 | 1321 | 0.720 |
Why?
| | Risk Adjustment | 1 | 2022 | 84 | 0.690 |
Why?
| | Early Medical Intervention | 1 | 2022 | 62 | 0.690 |
Why?
| | Blood Pressure | 7 | 2023 | 1752 | 0.670 |
Why?
| | Male | 100 | 2025 | 72189 | 0.660 |
Why?
| | Radiation Exposure | 1 | 2020 | 58 | 0.620 |
Why?
| | Intubation, Gastrointestinal | 3 | 2020 | 81 | 0.600 |
Why?
| | Hypotension | 3 | 2016 | 127 | 0.590 |
Why?
| | Patient Selection | 2 | 2022 | 699 | 0.570 |
Why?
| | Female | 78 | 2025 | 78217 | 0.560 |
Why?
| | Pylorus | 2 | 2010 | 18 | 0.560 |
Why?
| | Enteral Nutrition | 2 | 2020 | 217 | 0.560 |
Why?
| | Pyloric Stenosis, Hypertrophic | 2 | 2010 | 10 | 0.560 |
Why?
| | Catheterization, Central Venous | 2 | 2018 | 121 | 0.550 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 554 | 0.540 |
Why?
| | Lung Diseases | 7 | 2022 | 796 | 0.530 |
Why?
| | Colorado | 26 | 2022 | 4605 | 0.530 |
Why?
| | Head Injuries, Closed | 3 | 2012 | 50 | 0.490 |
Why?
| | Bacteremia | 1 | 2018 | 220 | 0.480 |
Why?
| | Bicycling | 1 | 2017 | 120 | 0.480 |
Why?
| | Hemoglobins | 3 | 2022 | 376 | 0.470 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 12 | 0.460 |
Why?
| | Gastrostomy | 2 | 2015 | 129 | 0.460 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 445 | 0.450 |
Why?
| | Intestinal Volvulus | 1 | 2015 | 23 | 0.450 |
Why?
| | Rehydration Solutions | 1 | 2014 | 8 | 0.440 |
Why?
| | Thrombosis | 1 | 2018 | 393 | 0.430 |
Why?
| | Isotonic Solutions | 1 | 2014 | 39 | 0.430 |
Why?
| | Shock, Traumatic | 1 | 2014 | 15 | 0.430 |
Why?
| | Lung | 14 | 2022 | 4190 | 0.430 |
Why?
| | Age Factors | 10 | 2025 | 3311 | 0.420 |
Why?
| | Infant, Newborn | 17 | 2020 | 6406 | 0.410 |
Why?
| | Multiple Trauma | 7 | 2014 | 118 | 0.400 |
Why?
| | Preoperative Care | 2 | 2015 | 379 | 0.400 |
Why?
| | Vascular System Injuries | 3 | 2021 | 80 | 0.390 |
Why?
| | Gastroesophageal Reflux | 1 | 2015 | 240 | 0.380 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2013 | 98 | 0.370 |
Why?
| | Laparotomy | 7 | 2023 | 113 | 0.370 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.370 |
Why?
| | Critical Illness | 2 | 2018 | 886 | 0.370 |
Why?
| | Tracheostomy | 1 | 2014 | 142 | 0.370 |
Why?
| | Registries | 12 | 2025 | 2253 | 0.360 |
Why?
| | Risk Assessment | 4 | 2021 | 3580 | 0.360 |
Why?
| | Sensitivity and Specificity | 6 | 2022 | 1987 | 0.360 |
Why?
| | Risk Factors | 15 | 2022 | 10672 | 0.360 |
Why?
| | Referral and Consultation | 1 | 2018 | 847 | 0.350 |
Why?
| | Prognosis | 10 | 2023 | 4253 | 0.340 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 241 | 0.320 |
Why?
| | Treatment Outcome | 18 | 2020 | 11581 | 0.300 |
Why?
| | Mass Screening | 2 | 2019 | 1331 | 0.280 |
Why?
| | Viscera | 2 | 2005 | 17 | 0.270 |
Why?
| | Survival Rate | 9 | 2025 | 2051 | 0.270 |
Why?
| | Critical Pathways | 1 | 2009 | 108 | 0.270 |
Why?
| | Wounds, Gunshot | 2 | 2022 | 259 | 0.260 |
Why?
| | Lipopolysaccharides | 10 | 2004 | 875 | 0.260 |
Why?
| | Thoracoscopy | 4 | 2006 | 60 | 0.260 |
Why?
| | Accidents, Home | 2 | 2004 | 33 | 0.250 |
Why?
| | Adult | 31 | 2025 | 40438 | 0.250 |
Why?
| | Endotoxins | 7 | 1999 | 220 | 0.240 |
Why?
| | Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 3 | 0.240 |
Why?
| | Radiation Dosage | 2 | 2020 | 190 | 0.230 |
Why?
| | Heart Arrest | 3 | 2018 | 404 | 0.220 |
Why?
| | Carcinoma, Papillary | 1 | 2025 | 80 | 0.220 |
Why?
| | Receptors, Adrenergic, beta | 3 | 1994 | 61 | 0.220 |
Why?
| | Digestive System Surgical Procedures | 1 | 2005 | 104 | 0.220 |
Why?
| | Follow-Up Studies | 9 | 2022 | 5350 | 0.210 |
Why?
| | Surgeons | 2 | 2021 | 341 | 0.210 |
Why?
| | Leg Injuries | 1 | 2004 | 24 | 0.210 |
Why?
| | Incidence | 12 | 2020 | 2865 | 0.210 |
Why?
| | Neutrophils | 13 | 2002 | 1146 | 0.200 |
Why?
| | Surgical Wound | 1 | 2023 | 27 | 0.190 |
Why?
| | Intestines | 2 | 2004 | 358 | 0.180 |
Why?
| | Precipitating Factors | 1 | 2022 | 6 | 0.180 |
Why?
| | Anticoagulants | 3 | 2019 | 721 | 0.180 |
Why?
| | Pediatric Emergency Medicine | 1 | 2022 | 23 | 0.180 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 5 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 126 | 0.180 |
Why?
| | Heart Injuries | 1 | 2021 | 41 | 0.170 |
Why?
| | Fundoplication | 2 | 2015 | 54 | 0.170 |
Why?
| | Intracranial Pressure | 1 | 2022 | 61 | 0.170 |
Why?
| | Hypovolemia | 1 | 2021 | 12 | 0.170 |
Why?
| | Logistic Models | 3 | 2016 | 2098 | 0.170 |
Why?
| | Jejunostomy | 1 | 2020 | 13 | 0.160 |
Why?
| | Early Diagnosis | 1 | 2022 | 247 | 0.160 |
Why?
| | Intraoperative Complications | 1 | 2022 | 155 | 0.160 |
Why?
| | Time Factors | 10 | 2014 | 7107 | 0.160 |
Why?
| | Stomach | 1 | 2020 | 109 | 0.160 |
Why?
| | Plasma | 1 | 2022 | 227 | 0.160 |
Why?
| | Postoperative Care | 3 | 2019 | 283 | 0.160 |
Why?
| | Frailty | 1 | 2023 | 193 | 0.160 |
Why?
| | Prospective Studies | 7 | 2022 | 7947 | 0.150 |
Why?
| | Hospital Mortality | 2 | 2014 | 980 | 0.150 |
Why?
| | Cerebrovascular Trauma | 1 | 2019 | 23 | 0.150 |
Why?
| | Salmonella typhimurium | 6 | 2002 | 192 | 0.150 |
Why?
| | Heart | 2 | 1994 | 635 | 0.150 |
Why?
| | Phlebotomy | 1 | 2019 | 21 | 0.150 |
Why?
| | Mortality | 1 | 2022 | 364 | 0.150 |
Why?
| | Respiration, Artificial | 3 | 2014 | 714 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 291 | 0.140 |
Why?
| | Diagnosis, Differential | 5 | 2014 | 1504 | 0.140 |
Why?
| | Isoproterenol | 4 | 1998 | 97 | 0.140 |
Why?
| | United States | 8 | 2025 | 15723 | 0.140 |
Why?
| | Central Venous Catheters | 1 | 2018 | 53 | 0.140 |
Why?
| | Platelet Activating Factor | 3 | 1992 | 49 | 0.140 |
Why?
| | Firearms | 2 | 2022 | 436 | 0.140 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 110 | 0.140 |
Why?
| | Cholestasis | 1 | 2000 | 211 | 0.130 |
Why?
| | Colforsin | 4 | 2001 | 48 | 0.130 |
Why?
| | Abdomen, Acute | 1 | 1997 | 20 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2022 | 1086 | 0.130 |
Why?
| | Patient Readmission | 2 | 2020 | 727 | 0.130 |
Why?
| | Stroke | 2 | 2019 | 1227 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 943 | 0.130 |
Why?
| | Health Care Costs | 1 | 2020 | 418 | 0.130 |
Why?
| | Immune System Diseases | 1 | 1997 | 40 | 0.130 |
Why?
| | Algorithms | 2 | 2021 | 1848 | 0.130 |
Why?
| | Hospital Charges | 1 | 2016 | 45 | 0.130 |
Why?
| | Hospitalization | 4 | 2016 | 2359 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 1147 | 0.120 |
Why?
| | Surgery Department, Hospital | 1 | 2016 | 23 | 0.120 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2015 | 338 | 0.120 |
Why?
| | Hospital Rapid Response Team | 1 | 2016 | 21 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2015 | 3411 | 0.120 |
Why?
| | Myocardial Reperfusion Injury | 4 | 1992 | 139 | 0.120 |
Why?
| | Cause of Death | 2 | 2014 | 461 | 0.120 |
Why?
| | Chemokines | 3 | 2001 | 224 | 0.120 |
Why?
| | Multiple Organ Failure | 4 | 2003 | 125 | 0.120 |
Why?
| | Exsanguination | 2 | 2012 | 20 | 0.120 |
Why?
| | Hemostatic Techniques | 1 | 2016 | 52 | 0.120 |
Why?
| | Splenectomy | 1 | 2015 | 66 | 0.120 |
Why?
| | Medical Futility | 1 | 2015 | 31 | 0.110 |
Why?
| | Funnel Chest | 2 | 2005 | 29 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2022 | 914 | 0.110 |
Why?
| | Research Design | 1 | 2022 | 1128 | 0.110 |
Why?
| | Intestine, Small | 1 | 1996 | 167 | 0.110 |
Why?
| | Specialization | 1 | 2016 | 134 | 0.110 |
Why?
| | Arterial Occlusive Diseases | 1 | 1995 | 89 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 185 | 0.110 |
Why?
| | Ultrasonography | 4 | 2010 | 766 | 0.110 |
Why?
| | Accidents | 1 | 2014 | 45 | 0.110 |
Why?
| | Child Advocacy | 1 | 2014 | 32 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 1997 | 281 | 0.100 |
Why?
| | Craniotomy | 1 | 2014 | 83 | 0.100 |
Why?
| | Macrophages, Peritoneal | 2 | 2004 | 89 | 0.100 |
Why?
| | Rats | 19 | 2002 | 5632 | 0.100 |
Why?
| | Critical Care | 3 | 2013 | 700 | 0.100 |
Why?
| | Radiography, Thoracic | 2 | 2013 | 176 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 403 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2016 | 317 | 0.100 |
Why?
| | Hemorrhage | 2 | 2016 | 801 | 0.100 |
Why?
| | Fluid Therapy | 1 | 2014 | 148 | 0.100 |
Why?
| | Motor Skills | 1 | 2014 | 106 | 0.100 |
Why?
| | Predictive Value of Tests | 4 | 2013 | 2103 | 0.100 |
Why?
| | Tracheotomy | 1 | 2013 | 23 | 0.100 |
Why?
| | Patient Outcome Assessment | 1 | 2014 | 133 | 0.100 |
Why?
| | Contrast Media | 2 | 2015 | 488 | 0.100 |
Why?
| | Embolization, Therapeutic | 1 | 2015 | 240 | 0.100 |
Why?
| | Pandemics | 1 | 2022 | 1685 | 0.100 |
Why?
| | Thrombophilia | 1 | 2013 | 88 | 0.100 |
Why?
| | Young Adult | 7 | 2025 | 14033 | 0.100 |
Why?
| | Coronary Disease | 1 | 1995 | 369 | 0.100 |
Why?
| | Urinalysis | 1 | 2013 | 81 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 53 | 0.090 |
Why?
| | Interleukin-10 | 3 | 2004 | 311 | 0.090 |
Why?
| | Vascular Surgical Procedures | 2 | 2012 | 343 | 0.090 |
Why?
| | Blood Group Incompatibility | 1 | 2012 | 20 | 0.090 |
Why?
| | Television | 1 | 1993 | 72 | 0.090 |
Why?
| | Forecasting | 1 | 2014 | 390 | 0.090 |
Why?
| | Phenytoin | 1 | 2012 | 21 | 0.090 |
Why?
| | Postoperative Complications | 6 | 2022 | 2934 | 0.090 |
Why?
| | Catheter-Related Infections | 1 | 2013 | 94 | 0.090 |
Why?
| | Abdominal Wound Closure Techniques | 1 | 2012 | 8 | 0.090 |
Why?
| | Piracetam | 1 | 2012 | 13 | 0.090 |
Why?
| | Angiography, Digital Subtraction | 1 | 2012 | 46 | 0.090 |
Why?
| | Electroencephalography | 1 | 2015 | 534 | 0.090 |
Why?
| | Orthopedic Procedures | 1 | 2014 | 235 | 0.090 |
Why?
| | Vasodilation | 4 | 1999 | 521 | 0.090 |
Why?
| | Chemokines, CXC | 2 | 2002 | 70 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2016 | 796 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 267 | 0.080 |
Why?
| | Aged | 8 | 2025 | 25822 | 0.080 |
Why?
| | Neutrophil Infiltration | 2 | 2002 | 105 | 0.080 |
Why?
| | Urinary Tract Infections | 1 | 2013 | 202 | 0.080 |
Why?
| | Thyroidectomy | 1 | 2011 | 91 | 0.080 |
Why?
| | Acute Disease | 6 | 2021 | 1006 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 10 | 2002 | 2538 | 0.080 |
Why?
| | Fat Necrosis | 1 | 1990 | 12 | 0.080 |
Why?
| | Myocardium | 4 | 1993 | 949 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2011 | 158 | 0.080 |
Why?
| | Endocrinology | 1 | 2011 | 77 | 0.080 |
Why?
| | Specialties, Surgical | 1 | 2011 | 81 | 0.080 |
Why?
| | Triamcinolone | 1 | 1989 | 13 | 0.080 |
Why?
| | Pericardium | 1 | 1990 | 61 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1531 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2013 | 1510 | 0.080 |
Why?
| | Chest Pain | 1 | 1990 | 94 | 0.080 |
Why?
| | Diaphragm | 2 | 2004 | 49 | 0.080 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2002 | 382 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2012 | 232 | 0.080 |
Why?
| | Suppuration | 1 | 2009 | 9 | 0.070 |
Why?
| | Biopsy | 1 | 1993 | 1071 | 0.070 |
Why?
| | Esophageal Stenosis | 1 | 1989 | 55 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 274 | 0.070 |
Why?
| | Necrosis | 1 | 1990 | 245 | 0.070 |
Why?
| | Oxygen | 2 | 1994 | 1003 | 0.070 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2004 | 1225 | 0.070 |
Why?
| | Pulmonary Fibrosis | 1 | 1993 | 404 | 0.070 |
Why?
| | Perioperative Care | 1 | 2011 | 223 | 0.070 |
Why?
| | Pediatrics | 2 | 2011 | 1099 | 0.070 |
Why?
| | Middle Aged | 10 | 2025 | 35939 | 0.070 |
Why?
| | General Surgery | 1 | 2011 | 207 | 0.070 |
Why?
| | Asparaginase | 2 | 1998 | 30 | 0.070 |
Why?
| | Accidents, Traffic | 4 | 2011 | 190 | 0.070 |
Why?
| | Seizures | 1 | 2012 | 458 | 0.070 |
Why?
| | Pulmonary Artery | 3 | 2000 | 1136 | 0.070 |
Why?
| | Aorta, Thoracic | 2 | 2021 | 288 | 0.070 |
Why?
| | Cyclic AMP | 2 | 2001 | 209 | 0.070 |
Why?
| | Patient Discharge | 2 | 2016 | 949 | 0.060 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2005 | 192 | 0.060 |
Why?
| | Hernia, Inguinal | 2 | 1998 | 43 | 0.060 |
Why?
| | Pancreatitis | 2 | 1998 | 138 | 0.060 |
Why?
| | Biliary Atresia | 2 | 2000 | 145 | 0.060 |
Why?
| | Pilot Projects | 1 | 2012 | 1873 | 0.060 |
Why?
| | Endotoxemia | 3 | 2002 | 88 | 0.060 |
Why?
| | Mediastinal Neoplasms | 1 | 2006 | 51 | 0.060 |
Why?
| | Hepatic Artery | 1 | 2006 | 54 | 0.060 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2006 | 44 | 0.060 |
Why?
| | Mediastinum | 1 | 2005 | 23 | 0.060 |
Why?
| | Brachial Plexus | 1 | 2005 | 35 | 0.060 |
Why?
| | Rats, Inbred Strains | 8 | 1992 | 321 | 0.060 |
Why?
| | Signal Transduction | 2 | 2002 | 5277 | 0.060 |
Why?
| | Patient Care Team | 1 | 2011 | 686 | 0.060 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2005 | 14 | 0.060 |
Why?
| | Hospitals, Teaching | 1 | 2005 | 116 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1913 | 0.060 |
Why?
| | Chemotactic Factors | 2 | 2002 | 43 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2009 | 711 | 0.060 |
Why?
| | Neuroblastoma | 1 | 2006 | 173 | 0.060 |
Why?
| | Kidney | 3 | 2004 | 1496 | 0.060 |
Why?
| | Growth Substances | 2 | 2002 | 141 | 0.050 |
Why?
| | Pulmonary Edema | 2 | 2002 | 106 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2025 | 1471 | 0.050 |
Why?
| | Cohort Studies | 1 | 2015 | 5898 | 0.050 |
Why?
| | Heparin | 2 | 2019 | 250 | 0.050 |
Why?
| | Renal Veins | 1 | 2004 | 18 | 0.050 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2005 | 120 | 0.050 |
Why?
| | Physical Examination | 2 | 2014 | 235 | 0.050 |
Why?
| | Leisure Activities | 1 | 2004 | 30 | 0.050 |
Why?
| | Renal Artery | 1 | 2004 | 43 | 0.050 |
Why?
| | Thoracic Surgical Procedures | 1 | 2005 | 95 | 0.050 |
Why?
| | Intestinal Perforation | 1 | 2004 | 46 | 0.050 |
Why?
| | Peroxidase | 7 | 2002 | 170 | 0.050 |
Why?
| | Granuloma, Plasma Cell | 1 | 2003 | 12 | 0.050 |
Why?
| | Comorbidity | 3 | 2023 | 1640 | 0.050 |
Why?
| | Hernia, Diaphragmatic | 1 | 2003 | 67 | 0.050 |
Why?
| | Age Distribution | 5 | 2003 | 396 | 0.050 |
Why?
| | Twins, Conjoined | 1 | 2003 | 6 | 0.050 |
Why?
| | Animals | 24 | 2002 | 38331 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 158 | 0.050 |
Why?
| | Pleural Effusion | 1 | 2003 | 60 | 0.050 |
Why?
| | Rib Fractures | 1 | 2003 | 33 | 0.050 |
Why?
| | Vital Signs | 1 | 2023 | 48 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2003 | 169 | 0.050 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2022 | 37 | 0.050 |
Why?
| | Pancreatectomy | 1 | 2025 | 286 | 0.050 |
Why?
| | Anal Canal | 1 | 2003 | 101 | 0.050 |
Why?
| | Diseases in Twins | 1 | 2003 | 116 | 0.050 |
Why?
| | Solitary Pulmonary Nodule | 1 | 2002 | 23 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 133 | 0.050 |
Why?
| | Chemokine CXCL2 | 4 | 2002 | 42 | 0.050 |
Why?
| | Peritonitis | 1 | 2002 | 84 | 0.040 |
Why?
| | Rectum | 1 | 2003 | 183 | 0.040 |
Why?
| | Receptors, Cell Surface | 2 | 2002 | 380 | 0.040 |
Why?
| | Bites and Stings | 1 | 2001 | 29 | 0.040 |
Why?
| | Abnormalities, Multiple | 1 | 2003 | 196 | 0.040 |
Why?
| | Patients | 1 | 2023 | 180 | 0.040 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2001 | 166 | 0.040 |
Why?
| | Consensus | 1 | 2023 | 482 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2004 | 512 | 0.040 |
Why?
| | Receptors, Interleukin-1 | 1 | 2002 | 214 | 0.040 |
Why?
| | Pulmonary Circulation | 2 | 1999 | 431 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2000 | 48 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 206 | 0.040 |
Why?
| | Joint Dislocations | 1 | 2000 | 56 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2004 | 962 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 27 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2019 | 26 | 0.040 |
Why?
| | Sex Distribution | 4 | 2002 | 381 | 0.040 |
Why?
| | Hydrogen Peroxide | 2 | 1992 | 340 | 0.040 |
Why?
| | Surgical Wound Infection | 1 | 2023 | 330 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 267 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 500 | 0.040 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 240 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 126 | 0.040 |
Why?
| | Odds Ratio | 1 | 2022 | 1058 | 0.040 |
Why?
| | Morbidity | 2 | 2014 | 322 | 0.040 |
Why?
| | Cervical Vertebrae | 1 | 2000 | 157 | 0.040 |
Why?
| | Salmonella typhi | 1 | 1998 | 12 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2023 | 8185 | 0.040 |
Why?
| | Receptors, Adrenergic, alpha | 2 | 2000 | 19 | 0.040 |
Why?
| | Hernia, Femoral | 1 | 1998 | 4 | 0.040 |
Why?
| | Edema | 1 | 1999 | 125 | 0.040 |
Why?
| | Antigens, CD | 1 | 2001 | 564 | 0.040 |
Why?
| | Monocytes | 1 | 2001 | 544 | 0.030 |
Why?
| | Monokines | 3 | 2002 | 22 | 0.030 |
Why?
| | Melanoma | 1 | 2005 | 813 | 0.030 |
Why?
| | Octreotide | 1 | 1998 | 24 | 0.030 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1999 | 132 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2005 | 863 | 0.030 |
Why?
| | Pneumonia | 1 | 2003 | 642 | 0.030 |
Why?
| | Cecal Diseases | 1 | 1997 | 3 | 0.030 |
Why?
| | Analysis of Variance | 4 | 2004 | 1309 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2011 | 488 | 0.030 |
Why?
| | Aorta | 1 | 2000 | 432 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 699 | 0.030 |
Why?
| | Survivors | 1 | 2020 | 515 | 0.030 |
Why?
| | Perfusion | 3 | 1992 | 247 | 0.030 |
Why?
| | Leukocyte Count | 2 | 2002 | 319 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 1992 | 1057 | 0.030 |
Why?
| | Abdominal Pain | 1 | 1997 | 145 | 0.030 |
Why?
| | Aspirin | 1 | 2019 | 389 | 0.030 |
Why?
| | Portoenterostomy, Hepatic | 1 | 1996 | 39 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 3 | 0.030 |
Why?
| | Hepatic Duct, Common | 1 | 1996 | 5 | 0.030 |
Why?
| | Reoperation | 2 | 2012 | 614 | 0.030 |
Why?
| | Sepsis | 1 | 2002 | 640 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2016 | 200 | 0.030 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 1996 | 54 | 0.030 |
Why?
| | Ketone Bodies | 2 | 1992 | 15 | 0.030 |
Why?
| | Recovery of Function | 2 | 2015 | 702 | 0.030 |
Why?
| | Receptors, Purinergic P1 | 1 | 1994 | 30 | 0.030 |
Why?
| | Stomach Volvulus | 1 | 1994 | 2 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 839 | 0.030 |
Why?
| | Pneumothorax | 2 | 2005 | 51 | 0.030 |
Why?
| | Ventricular Pressure | 1 | 1994 | 52 | 0.030 |
Why?
| | Disease-Free Survival | 2 | 2006 | 772 | 0.030 |
Why?
| | Tetralones | 1 | 1993 | 1 | 0.030 |
Why?
| | Adenylyl Cyclases | 1 | 1994 | 60 | 0.030 |
Why?
| | Myocardial Reperfusion | 1 | 1993 | 53 | 0.030 |
Why?
| | Cardiac Output | 1 | 1994 | 179 | 0.020 |
Why?
| | Thoracoscopes | 1 | 1993 | 2 | 0.020 |
Why?
| | Administration, Oral | 1 | 2016 | 844 | 0.020 |
Why?
| | Conversion to Open Surgery | 1 | 2013 | 22 | 0.020 |
Why?
| | Evaluation Studies as Topic | 1 | 1993 | 169 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2016 | 1267 | 0.020 |
Why?
| | NF-kappa B | 3 | 2001 | 671 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1998 | 2037 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 1994 | 300 | 0.020 |
Why?
| | Oligopeptides | 2 | 1991 | 267 | 0.020 |
Why?
| | Acetoacetates | 1 | 1992 | 2 | 0.020 |
Why?
| | Surgical Sponges | 1 | 2012 | 5 | 0.020 |
Why?
| | Hydroxybutyrates | 1 | 1992 | 15 | 0.020 |
Why?
| | Cost Control | 1 | 2012 | 37 | 0.020 |
Why?
| | Vertebral Artery | 1 | 2011 | 27 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 81 | 0.020 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2012 | 30 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1993 | 278 | 0.020 |
Why?
| | Carotid Artery Injuries | 1 | 2011 | 41 | 0.020 |
Why?
| | Blood Coagulation | 1 | 2013 | 272 | 0.020 |
Why?
| | Fever | 1 | 2013 | 311 | 0.020 |
Why?
| | Chemokine CXCL1 | 2 | 2002 | 76 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 155 | 0.020 |
Why?
| | Lipid A | 1 | 1991 | 28 | 0.020 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1991 | 35 | 0.020 |
Why?
| | Pelvic Bones | 1 | 1993 | 135 | 0.020 |
Why?
| | Cytokines | 1 | 1999 | 2100 | 0.020 |
Why?
| | Endovascular Procedures | 1 | 2016 | 383 | 0.020 |
Why?
| | Angiography | 1 | 2011 | 207 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 44 | 0.020 |
Why?
| | Neoplastic Syndromes, Hereditary | 1 | 2011 | 45 | 0.020 |
Why?
| | Hospitals, University | 1 | 2011 | 175 | 0.020 |
Why?
| | Pancreatic Elastase | 1 | 1990 | 55 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1990 | 87 | 0.020 |
Why?
| | Drug Costs | 1 | 2012 | 114 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2011 | 56 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2012 | 283 | 0.020 |
Why?
| | Antioxidants | 2 | 1991 | 581 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 201 | 0.020 |
Why?
| | Survival Analysis | 2 | 2003 | 1362 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1999 | 92 | 0.020 |
Why?
| | Growth Disorders | 1 | 1989 | 86 | 0.020 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 287 | 0.020 |
Why?
| | Liver Diseases | 1 | 1992 | 278 | 0.020 |
Why?
| | RNA, Messenger | 3 | 2002 | 2860 | 0.020 |
Why?
| | Shock, Septic | 1 | 1991 | 217 | 0.020 |
Why?
| | Reperfusion Injury | 1 | 1992 | 301 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1991 | 233 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 621 | 0.020 |
Why?
| | Lung Neoplasms | 1 | 2002 | 2645 | 0.020 |
Why?
| | Radiology | 1 | 2011 | 176 | 0.020 |
Why?
| | Glutathione | 1 | 1990 | 379 | 0.020 |
Why?
| | Fractures, Bone | 1 | 1993 | 417 | 0.020 |
Why?
| | Medical Oncology | 1 | 2011 | 332 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 463 | 0.020 |
Why?
| | Thyroid Neoplasms | 1 | 2011 | 346 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 1998 | 2224 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 1990 | 1099 | 0.020 |
Why?
| | Serum Albumin | 3 | 1992 | 150 | 0.020 |
Why?
| | Enzyme Inhibitors | 2 | 2000 | 832 | 0.020 |
Why?
| | Tissue Adhesions | 1 | 2006 | 34 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 1992 | 675 | 0.010 |
Why?
| | Equipment Failure | 1 | 2006 | 113 | 0.010 |
Why?
| | Arm | 1 | 2005 | 109 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2006 | 111 | 0.010 |
Why?
| | Hypertension, Renovascular | 1 | 2004 | 15 | 0.010 |
Why?
| | Posture | 1 | 2005 | 197 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 337 | 0.010 |
Why?
| | Rupture | 1 | 2004 | 86 | 0.010 |
Why?
| | Subclavian Vein | 1 | 2003 | 15 | 0.010 |
Why?
| | Hemothorax | 1 | 2003 | 12 | 0.010 |
Why?
| | Abdominal Abscess | 1 | 2003 | 25 | 0.010 |
Why?
| | Jugular Veins | 1 | 2003 | 42 | 0.010 |
Why?
| | Rectovaginal Fistula | 1 | 2003 | 11 | 0.010 |
Why?
| | Appendix | 1 | 2003 | 31 | 0.010 |
Why?
| | Fetal Death | 1 | 2003 | 58 | 0.010 |
Why?
| | Gene Expression Regulation | 2 | 2004 | 2633 | 0.010 |
Why?
| | Zymosan | 1 | 2002 | 39 | 0.010 |
Why?
| | Creatinine | 1 | 2004 | 492 | 0.010 |
Why?
| | Renal Insufficiency | 1 | 2004 | 167 | 0.010 |
Why?
| | Safety | 1 | 2004 | 353 | 0.010 |
Why?
| | Medical Errors | 1 | 2003 | 120 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2002 | 251 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2001 | 42 | 0.010 |
Why?
| | Probability | 1 | 2002 | 306 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 184 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 2003 | 176 | 0.010 |
Why?
| | Bucladesine | 1 | 2001 | 20 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 81 | 0.010 |
Why?
| | Catalase | 2 | 1992 | 136 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 158 | 0.010 |
Why?
| | Vinblastine | 2 | 1992 | 75 | 0.010 |
Why?
| | Spine | 1 | 2003 | 181 | 0.010 |
Why?
| | Toll-Like Receptor 2 | 1 | 2002 | 126 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2002 | 195 | 0.010 |
Why?
| | Nitrites | 1 | 2001 | 89 | 0.010 |
Why?
| | I-kappa B Proteins | 1 | 2001 | 74 | 0.010 |
Why?
| | Vagina | 1 | 2003 | 202 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 254 | 0.010 |
Why?
| | omega-N-Methylarginine | 1 | 2000 | 29 | 0.010 |
Why?
| | Nitrates | 1 | 2001 | 100 | 0.010 |
Why?
| | Guanidines | 1 | 2000 | 41 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 83 | 0.010 |
Why?
| | I-kappa B Kinase | 1 | 2000 | 51 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2001 | 125 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 260 | 0.010 |
Why?
| | Renal Dialysis | 1 | 2004 | 460 | 0.010 |
Why?
| | Recurrence | 1 | 2003 | 1125 | 0.010 |
Why?
| | Dogs | 1 | 2001 | 438 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2002 | 277 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 858 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 165 | 0.010 |
Why?
| | Interleukin-6 | 1 | 2004 | 791 | 0.010 |
Why?
| | Immunoblotting | 1 | 2000 | 307 | 0.010 |
Why?
| | Animals, Newborn | 1 | 2002 | 904 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2000 | 328 | 0.010 |
Why?
| | Mice | 3 | 2002 | 18549 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2002 | 393 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2002 | 650 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 2000 | 376 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 402 | 0.010 |
Why?
| | Histamine Agonists | 1 | 1998 | 1 | 0.010 |
Why?
| | Niacinamide | 1 | 1999 | 86 | 0.010 |
Why?
| | Dimaprit | 1 | 1998 | 3 | 0.010 |
Why?
| | Blood Circulation | 1 | 1998 | 44 | 0.010 |
Why?
| | Vas Deferens | 1 | 1998 | 11 | 0.010 |
Why?
| | Benzamides | 1 | 1999 | 226 | 0.010 |
Why?
| | Prevalence | 1 | 2005 | 2830 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1358 | 0.010 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 95 | 0.010 |
Why?
| | Placebo Effect | 1 | 1997 | 25 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 854 | 0.010 |
Why?
| | Vascular Resistance | 1 | 1998 | 366 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2000 | 432 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 977 | 0.010 |
Why?
| | Sex Factors | 1 | 2003 | 2090 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1999 | 499 | 0.010 |
Why?
| | Graft Rejection | 1 | 2000 | 538 | 0.010 |
Why?
| | Intraoperative Period | 1 | 1996 | 68 | 0.010 |
Why?
| | Hospital Costs | 1 | 1997 | 122 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4177 | 0.010 |
Why?
| | Energy Metabolism | 2 | 1993 | 946 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1517 | 0.010 |
Why?
| | Iothalamate Meglumine | 1 | 1996 | 2 | 0.010 |
Why?
| | Cholangiography | 1 | 1996 | 10 | 0.010 |
Why?
| | Traction | 1 | 1996 | 19 | 0.010 |
Why?
| | Gallbladder | 1 | 1996 | 15 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2000 | 360 | 0.010 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 1996 | 63 | 0.010 |
Why?
| | Dissection | 1 | 1996 | 56 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2000 | 1054 | 0.010 |
Why?
| | Single-Blind Method | 1 | 1996 | 310 | 0.010 |
Why?
| | DNA | 1 | 2001 | 1430 | 0.010 |
Why?
| | Phenethylamines | 1 | 1993 | 19 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2000 | 3147 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 254 | 0.010 |
Why?
| | Norepinephrine | 1 | 1993 | 196 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 83 | 0.010 |
Why?
| | Nitroblue Tetrazolium | 1 | 1991 | 12 | 0.010 |
Why?
| | Ventricular Function | 1 | 1991 | 57 | 0.010 |
Why?
| | Tungsten | 1 | 1991 | 30 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4605 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1991 | 115 | 0.010 |
Why?
| | Arrhythmias, Cardiac | 1 | 1993 | 352 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 149 | 0.010 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 1 | 1990 | 39 | 0.010 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1990 | 24 | 0.010 |
Why?
| | Azepines | 1 | 1991 | 107 | 0.010 |
Why?
| | Permeability | 1 | 1991 | 168 | 0.010 |
Why?
| | Endothelium | 1 | 1991 | 119 | 0.000 |
Why?
| | Triazoles | 1 | 1991 | 185 | 0.000 |
Why?
| | Cell Adhesion | 1 | 1991 | 457 | 0.000 |
Why?
| | Liver Transplantation | 1 | 1996 | 792 | 0.000 |
Why?
| | Kinetics | 1 | 1992 | 1627 | 0.000 |
Why?
| | Biomechanical Phenomena | 1 | 1990 | 876 | 0.000 |
Why?
| | Proteins | 1 | 1991 | 1029 | 0.000 |
Why?
| | Diet | 1 | 1991 | 1277 | 0.000 |
Why?
|
|
Bensard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|